Postma MJ - Search Results

1

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation.

Jacobs MS, de Jong LA, Postma MJ, Tieleman RG, van Hulst M. Jacobs MS, et al. Among authors: postma mj. Eur J Health Econ. 2018 Sep;19(7):957-965. doi: 10.1007/s10198-017-0942-2. Epub 2017 Nov 27. Eur J Health Econ. 2018. PMID: 29181817 Free PMC article.

2

Pharmaco-economics of blood transfusion safety: review of the available evidence.

van Hulst M, de Wolf JT, Staginnus U, Ruitenberg EJ, Postma MJ. van Hulst M, et al. Among authors: postma mj. Vox Sang. 2002 Aug;83(2):146-55. doi: 10.1046/j.1423-0410.2002.00198.x. Vox Sang. 2002. PMID: 12201844 Review.

3

Cost-effectiveness of leucocyte depletion of red-cell transfusions for patients undergoing cardiac surgery.

Postma MJ, van de Watering LM, de Vries R, Versmoren D, van Hulst M, Tobi H, van der Poel CL, Brand A. Postma MJ, et al. Vox Sang. 2003 Jan;84(1):65-7. doi: 10.1046/j.1423-0410.2003.00245.x. Vox Sang. 2003. PMID: 12542735 No abstract available.

4

Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery.

van Hulst M, Bilgin YM, van de Watering LM, de Vries R, van Oers MH, Brand A, Postma MJ. van Hulst M, et al. Among authors: postma mj. Transfus Med. 2005 Jun;15(3):209-17. doi: 10.1111/j.1365-3148.2005.00573.x. Transfus Med. 2005. PMID: 15943705

5

Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands.

Postma MJ, van Hulst M, De Wolf JT, Botteman M, Staginnus U. Postma MJ, et al. Transfus Med. 2005 Oct;15(5):379-87. doi: 10.1111/j.1365-3148.2005.00609.x. Transfus Med. 2005. PMID: 16202052

6

Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.

Klok RM, Arents NL, de Vries R, Thijs JC, Brouwers JR, Kleibeuker JH, Postma MJ. Klok RM, et al. Among authors: postma mj. Clin Ther. 2005 Oct;27(10):1647-57. doi: 10.1016/j.clinthera.2005.10.011. Clin Ther. 2005. PMID: 16330302

7

Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands.

Bos JM, Rümke HC, Welte R, Spanjaard L, van Alphen L, Postma MJ. Bos JM, et al. Among authors: postma mj. Pharmacoeconomics. 2006;24(2):141-53. doi: 10.2165/00019053-200624020-00004. Pharmacoeconomics. 2006. PMID: 16460135

8

Costs of chemotherapy in the treatment of colorectal cancer.

Jansman FG, Postma MJ. Jansman FG, et al. Among authors: postma mj. Eur J Health Econ. 2006 Jun;7(2):145-6. doi: 10.1007/s10198-006-0356-z. Eur J Health Econ. 2006. PMID: 16699776 No abstract available.

9

Health economic methodology illustrated with recent work on Chlamydia screening: the concept of extended dominance.

Postma MJ, de Vries R, Welte R, Edmunds WJ. Postma MJ, et al. Sex Transm Infect. 2008 Apr;84(2):152-4. doi: 10.1136/sti.2007.028043. Epub 2007 Dec 12. Sex Transm Infect. 2008. PMID: 18077610

10

Economic evaluation of folic acid food fortification in The Netherlands.

Jentink J, van de Vrie-Hoekstra NW, de Jong-van den Berg LT, Postma MJ. Jentink J, et al. Among authors: postma mj. Eur J Public Health. 2008 Jun;18(3):270-4. doi: 10.1093/eurpub/ckm129. Epub 2008 Jan 31. Eur J Public Health. 2008. PMID: 18238826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters